CD163 and metabolic disease: CD163, CD206, and arginase-1 (Arg-1) act as makers of an alternative activation of monocytes/macrophages (M2, anti-inflammatory phenotype) (48), and play a crucial role in chronic inflammation of obesity-related metabolic diseases (49, 50).